Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
Recruiting · NCT05285917 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 3 | 2026-08-20 | NCT05285917 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brown University | 104 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Novartis | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Geral dos Cajueiros | Luanda | Angola | 1 |